We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
The MHRA is asking for views on a proposal to make Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) available without prescription in general sales outlets, such a supermarkets.
Study protocol for a randomized controlled trial in Regional Anesthesia Techniques for a Planned Randomized Controlled Trial in a Disaster Setting
Resource to support healthcare professionals to manage persistent pain in prison and secure environments.
Insufficient pain management is common in disaster settings, and regional anesthesia has the potential to reduce pain in injured patients
How to use a cost utility analysis to evaluate your digital health product.
‘WorkWell’ pilots to provide tailored support for people in their local area so people can stay and progress in work.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).